Coffee and tea consumption in relation to prostate cancer prognosis

Abstract

Background

Bioactive compounds found in coffee and tea may delay the progression of prostate cancer.

Methods

We investigated associations of pre-diagnostic coffee and tea consumption with risk of prostate cancer recurrence/progression. Study participants were men diagnosed with prostate cancer in 2002–2005 in King County, Washington, USA. We assessed the usual pattern of coffee and tea consumption two years before diagnosis date. Prostate cancer-specific outcome events were identified using a detailed follow-up survey. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs).

Results

The analysis of coffee intake in relation to prostate cancer recurrence/progression included 630 patients with a median follow-up of 6.4 years, during which 140 prostate cancer recurrence/progression events were recorded. Approximately 61 % of patients consumed at least one cup of coffee per day. Coffee consumption was associated with a reduced risk of prostate cancer recurrence/progression; the adjusted HR for ≥4 cups/day versus ≤1 cup/week was 0.41 (95 % CI: 0.20, 0.81; p for trend = 0.01). Approximately 14 % of patients consumed one or more cups of tea per day, and tea consumption was unrelated to prostate cancer recurrence/progression.

Conclusion

Results indicate that higher pre-diagnostic coffee consumption is associated with a lower risk of prostate cancer recurrence/progression. This finding will require replication in larger studies.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Wilson KM, Kasperzyk JL, Rider JR et al (2011) Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study. J Natl Cancer Inst 103:876–884

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Arab L (2010) Epidemiologic evidence on coffee and cancer. Nutr Cancer 62:271–283

    PubMed  Article  Google Scholar 

  3. 3.

    Farah A, Monteiro M, Donangelo CM, Lafay S (2008) Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 138:2309–2315

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–123

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Nkondjock A (2009) Coffee consumption and the risk of cancer: an overview. Cancer Lett 277:121–125

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Yang H, Rouse J, Lukes L et al (2004) Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis 21:719–735

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89–143

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H (2011) Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res 64:113–122

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Connors SK, Chornokur G, Kumar NB (2012) New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer 64:4–22

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Henning SM, Wang P, Heber D (2011) Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res 55:905–920

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Johnson JJ, Bailey HH, Mukhtar H (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17:3–13

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL (2008) Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168:250–260

    PubMed  Article  Google Scholar 

  13. 13.

    Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T (1999) Measurement characteristics of the women’s health initiative food frequency questionnaire. Ann Epidemiol 9:178–187

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Yuan JM, Sun C, Butler LM (2011) Tea and cancer prevention: epidemiological studies. Pharmacol Res 64:123–135

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Roach M 3rd, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965–974

    PubMed  Article  Google Scholar 

  16. 16.

    Wright JL, Kwon EM, Lin DW et al (2010) CYP17 polymorphisms and prostate cancer outcomes. Prostate 70:1094–1101

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526

    Article  Google Scholar 

  18. 18.

    Denham JW, Steigler A, Wilcox C et al (2009) Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? Cancer 115:4477–4487

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Arab L, Su LJ, Steck SE et al (2012) Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Nutr Cancer 64:637–642

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Geybels MS, Neuhouser ML, Stanford JL. (2012) Associations of tea and coffee consumption with prostate cancer risk. Cancer causes & control: CCC (accepted)

  21. 21.

    Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS (2012) Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 11:42

    PubMed  Article  Google Scholar 

  22. 22.

    Klotz L (2012) Active surveillance: the canadian experience with an “inclusive approach”. J Natl Cancer Inst Monogr 2012:234–241

    PubMed  Article  Google Scholar 

  23. 23.

    Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366:1891–1904

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Hashimoto T, He Z, Ma WY et al (2004) Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 64:3344–3349

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, Dong Z (2003) Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 63:4396–4401

    PubMed  CAS  Google Scholar 

  26. 26.

    Song F, Qureshi AA, Han J (2012) Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res 72:3282–3289

    PubMed  Article  CAS  Google Scholar 

  27. 27.

    Holick CN, Smith SG, Giovannucci E, Michaud DS (2010) Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev 19:39–47

    PubMed  Article  CAS  Google Scholar 

  28. 28.

    Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE (2008) Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 112:1169–1177

    PubMed  Article  Google Scholar 

  29. 29.

    Huber WW, Rossmanith W, Grusch M et al (2008) Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 46:1230–1238

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290–1300

    PubMed  Article  CAS  Google Scholar 

  31. 31.

    Lee WJ, Zhu BT (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27:269–277

    PubMed  Article  CAS  Google Scholar 

  32. 32.

    Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Cancer Institute (R01-CA092579 and P50-CA097186) and a grant from the Dutch Cancer Society (UM 2009-4556). Additional support was provided by the Fred Hutchinson Cancer Research Center and the Prostate Cancer Foundation.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Janet L. Stanford.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Geybels, M.S., Neuhouser, M.L., Wright, J.L. et al. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control 24, 1947–1954 (2013). https://doi.org/10.1007/s10552-013-0270-5

Download citation

Keywords

  • Prostate cancer
  • Progression
  • Biochemical recurrence
  • Mortality
  • Coffee
  • Tea